Literature DB >> 8892903

Comparative analysis identifies conserved tumor necrosis factor receptor-associated factor 3 binding sites in the human and simian Epstein-Barr virus oncogene LMP1.

M Franken1, O Devergne, M Rosenzweig, B Annis, E Kieff, F Wang.   

Abstract

Nonhuman primates are naturally infected with a B-lymphotropic herpesvirus closely related to Epstein-Barr virus (EBV). These simian EBV share considerable genetic, biologic, and epidemiologic features with human EBV, including virus-induced tumorigenesis. However, latent, transformation-associated viral genes demonstrate marked sequence divergence among species despite the conserved functions. We have cloned the latent membrane protein 1 (LMP1) homologs from the simian EBV naturally infecting baboons (cercopithicine herpesvirus 12, herpesvirus papio) and rhesus monkeys (cercopithicine herpesvirus 15) for a comparative study with the human EBV oncogene. The transmembrane domains are well conserved, but there is striking sequence divergence of the carboxy-terminal cytoplasmic domain essential for B-cell immortalization and interaction with the tumor necrosis factor receptor signaling pathway. Nevertheless, the simian EBV LMP1s retain most functions in common with EBV LMP1, including the ability to induce NF-(kappa)B activity in human cells, to bind the tumor necrosis factor-associated factor 3 (TRAF3) in vitro, and to induce expression of tumor necrosis factor-responsive genes, such as ICAM1, in human B lymphocytes. Multiple TRAF3 binding sites containing a PXQXT/S core sequence can be identified in the simian EBV LMP1s by an in vitro binding assay. A PXQXT/S-containing sequence is also present in the cytoplasmic domain of the Hodgkin's disease marker, CD30, and binds TRAF3 in vitro. The last 13 amino acids containing a PXQXT/S sequence are highly conserved in human and simian EBV LMP1 but do not bind TRAF3, suggesting a distinct role for this conserved region of LMP1. The conserved TRAF3 binding sites in LMP1 and the CD30 Hodgkin's disease marker provides further evidence that a TRAF3-mediated signal transduction pathway may be important in malignant transformation.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8892903      PMCID: PMC190852     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  48 in total

1.  A novel RING finger protein interacts with the cytoplasmic domain of CD40.

Authors:  H M Hu; K O'Rourke; M S Boguski; V M Dixit
Journal:  J Biol Chem       Date:  1994-12-02       Impact factor: 5.157

2.  The Epstein-Barr virus latent membrane protein-1 (LMP1) mediates activation of NF-kappa B and cell surface phenotype via two effector regions in its carboxy-terminal cytoplasmic domain.

Authors:  D S Huen; S A Henderson; D Croom-Carter; M Rowe
Journal:  Oncogene       Date:  1995-02-02       Impact factor: 9.867

Review 3.  CD30 (Ki-1) molecule: a new cytokine receptor of the tumor necrosis factor receptor superfamily as a tool for diagnosis and immunotherapy.

Authors:  B Falini; S Pileri; G Pizzolo; H Dürkop; L Flenghi; F Stirpe; M F Martelli; H Stein
Journal:  Blood       Date:  1995-01-01       Impact factor: 22.113

4.  Sequence variation in the Epstein-Barr virus latent membrane protein 1.

Authors:  W E Miller; R H Edwards; D M Walling; N Raab-Traub
Journal:  J Gen Virol       Date:  1994-10       Impact factor: 3.891

5.  Epstein-Barr virus (EBV) latent membrane protein 1 increases HLA class II expression in an EBV-negative B cell line.

Authors:  Q Zhang; L Brooks; P Busson; F Wang; D Charron; E Kieff; A B Rickinson; T Tursz
Journal:  Eur J Immunol       Date:  1994-06       Impact factor: 5.532

6.  HLA A2.1-restricted cytotoxic T cells recognizing a range of Epstein-Barr virus isolates through a defined epitope in latent membrane protein LMP2.

Authors:  S P Lee; W A Thomas; R J Murray; F Khanim; S Kaur; L S Young; M Rowe; M Kurilla; A B Rickinson
Journal:  J Virol       Date:  1993-12       Impact factor: 5.103

7.  Epstein-Barr virus types 1 and 2 have nearly identical LMP-1 transforming genes.

Authors:  J Sample; E F Kieff; E D Kieff
Journal:  J Gen Virol       Date:  1994-10       Impact factor: 3.891

8.  Contribution of conserved amino acids in mediating the interaction between EBNA2 and CBF1/RBPJk.

Authors:  P D Ling; S D Hayward
Journal:  J Virol       Date:  1995-03       Impact factor: 5.103

9.  The Epstein-Barr virus LMP1 cytoplasmic carboxy terminus is essential for B-lymphocyte transformation; fibroblast cocultivation complements a critical function within the terminal 155 residues.

Authors:  K M Kaye; K M Izumi; G Mosialos; E Kieff
Journal:  J Virol       Date:  1995-02       Impact factor: 5.103

10.  Upregulation of bcl-2 by the Epstein-Barr virus latent membrane protein LMP1: a B-cell-specific response that is delayed relative to NF-kappa B activation and to induction of cell surface markers.

Authors:  M Rowe; M Peng-Pilon; D S Huen; R Hardy; D Croom-Carter; E Lundgren; A B Rickinson
Journal:  J Virol       Date:  1994-09       Impact factor: 5.103

View more
  46 in total

1.  Inhibition of antigen presentation by the glycine/alanine repeat domain is not conserved in simian homologues of Epstein-Barr virus nuclear antigen 1.

Authors:  N W Blake; A Moghaddam; P Rao; A Kaur; R Glickman; Y G Cho; A Marchini; T Haigh; R P Johnson; A B Rickinson; F Wang
Journal:  J Virol       Date:  1999-09       Impact factor: 5.103

2.  Structural, functional, and genetic comparisons of Epstein-Barr virus nuclear antigen 3A, 3B, and 3C homologues encoded by the rhesus lymphocryptovirus.

Authors:  H Jiang; Y G Cho; F Wang
Journal:  J Virol       Date:  2000-07       Impact factor: 5.103

Review 3.  Signaling activities of gammaherpesvirus membrane proteins.

Authors:  B Damania; J K Choi; J U Jung
Journal:  J Virol       Date:  2000-02       Impact factor: 5.103

4.  Transcriptional regulatory properties of Epstein-Barr virus nuclear antigen 3C are conserved in simian lymphocryptoviruses.

Authors:  Bo Zhao; Rozenn Dalbiès-Tran; Hua Jiang; Ingrid K Ruf; Jeffery T Sample; Fred Wang; Clare E Sample
Journal:  J Virol       Date:  2003-05       Impact factor: 5.103

5.  The collagen repeat sequence is a determinant of the degree of herpesvirus saimiri STP transforming activity.

Authors:  J K Choi; S Ishido; J U Jung
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

6.  Sequence and functional analysis of EBNA-LP and EBNA2 proteins from nonhuman primate lymphocryptoviruses.

Authors:  R Peng; A V Gordadze; E M Fuentes Pananá; F Wang; J Zong; G S Hayward; J Tan; P D Ling
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

7.  The in vivo function of a noncanonical TRAF2-binding domain in the C-terminus of CD40 in driving B-cell growth and differentiation.

Authors:  Li-Fan Lu; Cory L Ahonen; Evan F Lind; Vanitha S Raman; W James Cook; Ling-Li Lin; Randolph J Noelle
Journal:  Blood       Date:  2007-03-14       Impact factor: 22.113

8.  The ID proteins contribute to the growth of rodent fibroblasts during LMP1-mediated transformation.

Authors:  David N Everly; Bernardo A Mainou; Nancy Raab-Traub
Journal:  Virology       Date:  2008-05-05       Impact factor: 3.616

9.  Transcriptional downregulation of p27KIP1 through regulation of E2F function during LMP1-mediated transformation.

Authors:  David N Everly; Bernardo A Mainou; Nancy Raab-Traub
Journal:  J Virol       Date:  2009-10-14       Impact factor: 5.103

10.  Mechanisms that regulate Epstein-Barr virus EBNA-1 gene transcription during restricted latency are conserved among lymphocryptoviruses of Old World primates.

Authors:  I K Ruf; A Moghaddam; F Wang; J Sample
Journal:  J Virol       Date:  1999-03       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.